跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TADALAFILO JUBILANT 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TADALAFILO JUBILANT 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
TADALAFILO JUBILANT 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Jubilant Pharmaceuticals
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 22, 2021
Approval ID
b5c4c3556ec1314e
Company
Jubilant Pharmaceuticals
Type
Standard
Approval Details
Approval Id
b5c4c3556ec1314e
Drug Cima Aemps Name
TADALAFILO JUBILANT 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86349
Holder Company Name
Jubilant Pharmaceuticals
Marketing Company Name
Jubilant Pharmaceuticals
Authorization Date
2021-10-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Jubilant Pharmaceuticals
Active Ingredients
TADALAFILO
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 22, 2021
Approval ID
b5c4c3556ec1314e
Type
Standard
Back to CIMA-AEMPS Approvals